---

Lars Rebien Sørensen

Chief Executive Officer, Novo Nordisk A/S

Revenue: DKK 88.8 billion ($12.9 billion) (2014)
Employees: circa 41,500

Lars Rebien Sørensen joined Novo Nordisk’s Enzymes Marketing in 1982 and in May 1994 he was appointed a member of Corporate Management. He was appointed president and CEO in November 2000.

www.novonordisk.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015